首页> 外文期刊>Iranian journal of medical hypotheses and ideas. >Bacterial infection-mediated anticancer activity (BIMAc) – Revisiting the molecular mechanisms
【24h】

Bacterial infection-mediated anticancer activity (BIMAc) – Revisiting the molecular mechanisms

机译:细菌感染介导的抗癌活性(BIMAc)–重新探讨分子机制

获取原文
           

摘要

The anticancer activity demonstrated by genetically attenuated invasive Shigella flexneri contradicts the long-held understanding of bacterial infection-mediated anticancer activity (BIMAc), as a ‘by-stander effect’ caused by an immune response against any invading pathogen as a reason for tumour regression. Similarly, the selective tumouricidal effect by Salmonella A1 auxotrophic mutant in nude mice is another observation where the current theory fails. Considering these flaws, we set to re-examine the mechanisms behind BIMAc independent of immune response, on the basis of molecular understanding about the initial colonisation of gut epithelium by S. flexneri and its production of cell-cycle-inhibiting proteins called cyclomodulins. During infection, S. flexneri injects OspE effector protein into the gut epithelium. The resulting interaction of OspE with ILK prevents epithelial cell exfoliation and facilitates the pathogen’s colonisation of the gut. This interaction is also shown to enhance membrane retention of ILK in these infected cells. Correspondingly, another study reports the indispensable role of ILK in survival of cancer cells with supernumerary centrosomes by localising it to the centrosomes and clustering them into a bipolar spindle. Knockdown of ILK in these cells leads to apoptosis due to multipolar mitosis. From these cumulative facts we hypothesised that enhanced membrane retention of ILK in Shigella-infected cancer cells prevents localisation of ILK to centrosomes and provokes multipolar mitosis and therefore cell death in cancer subpopulations with supernumerary centrosomes. This interaction may also be metastasis suppressive, because of its inhibitory effect on the focal adhesion turnover of gut epithelium, which is quintessential for any form of cell migration. Apart from these, Shigella also encodes potent cell-cycle-inhibiting effector molecules such as cyclomodulins. The additive action of these cyclomodulins along with the OspE–ILK interaction may be considered as the reason behind the anticancer activity mediated by Shigella infection.
机译:遗传减毒侵袭性志贺氏杆菌证明的抗癌活性与长期以来对细菌感染介导的抗癌活性(BIMAc)的理解相矛盾,BIMAc是由对任何入侵病原体的免疫应答引起的“旁观者效应”,这是肿瘤消退的原因。 。同样,沙门氏菌A1营养缺陷型突变体在裸鼠中的选择性杀肿瘤作用是当前理论失败的另一个观察结果。考虑到这些缺陷,我们将基于对弗氏链球菌对肠道上皮细胞的最初定植及其产生的细胞周期抑制蛋白(称为环调节蛋白)的分子理解,重新研究BIMAc背后独立于免疫应答的机制。在感染过程中,弗氏链球菌将OspE效应蛋白注入肠道上皮。 OspE与ILK的相互作用最终阻止了上皮细胞的脱落,并促进了病原体在肠道中的定殖。还显示这种相互作用增强了这些感染细胞中ILK的膜保留。相应地,另一项研究报道了ILK在具有多余中心体的癌细胞存活中不可或缺的作用,方法是将ILK定位在中心体上并将它们聚集成双极纺锤体。这些细胞中ILK的抑制导致多极有丝分裂导致的细胞凋亡。从这些累积的事实中,我们假设在志贺氏菌感染的癌细胞中,ILK的膜保留能力增强,可阻止ILK定位于中心体,并引起多极有丝分裂,从而在具有多中心体的癌症亚群中引起细胞死亡。这种相互作用也可能是转移抑制的,因为它对肠道上皮的粘着斑更新具有抑制作用,这对于任何形式的细胞迁移都是最典型的。除此之外,志贺氏菌还编码有效的细胞周期抑制效应分子,例如环调节蛋白。这些环调节蛋白的加和作用以及OspE-ILK相互作用可能被认为是由志贺氏菌感染介导的抗癌活性背后的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号